396 Followers on Owler
OverviewCompetitorsAcquisitionsNews & Insights

Par Pharmaceutical Competitors or Alternatives

Par Pharmaceutical's top competitors include TEVA, Sandoz and Mylan.

Unlock 13 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Par Pharmaceutical's company profile

CEO

- -
1,000 - 5,000
$0
$500M - 1B
  • $0
    $500M - 1B
  • 1,000 - 5,000
    $0
  • $500M - 1B
  • - -
  • 1,000 - 5,000
  • $0
  • $500M - 1B
View ProfileView
1
Par Pharmaceutical's Competitor - TEVA logo

Richard Francis

President & CEO

82/100
36,830
$13.9B
$16.5B
  • $13.9B
    $16.5B
  • 36,830
    $13.9B
  • $16.5B
  • 82/100
  • 36,830
  • $13.9B
  • $16.5B
View ProfileView
2
Par Pharmaceutical's Competitor - Sandoz logo

Richard Saynor

CEO

60/100
21,738
- -
$10.2B
  • - -
    $10.2B
  • 21,738
    - -
  • $10.2B
  • 60/100
  • 21,738
  • - -
  • $10.2B
View ProfileView
3
Par Pharmaceutical's Competitor - Mylan logo

CEO

- -
10,000 - 50,000
$7.9B
$10B - 50B
  • $7.9B
    $10B - 50B
  • 10,000 - 50,000
    $7.9B
  • $10B - 50B
  • - -
  • 10,000 - 50,000
  • $7.9B
  • $10B - 50B
View ProfileView
4
Par Pharmaceutical's Competitor - Apotex logo

Allan Oberman

President & CEO

82/100
5,000 - 10,000
$8.2M
$1B - 5B
  • $8.2M
    $1B - 5B
  • 5,000 - 10,000
    $8.2M
  • $1B - 5B
  • 82/100
  • 5,000 - 10,000
  • $8.2M
  • $1B - 5B
View ProfileView
5
Par Pharmaceutical's Competitor - Bluefish Pharmaceuticals logo

Berit Lindholm

CEO

82/100
100 - 250
- -
$25M - 100M
  • - -
    $25M - 100M
  • 100 - 250
    - -
  • $25M - 100M
  • 82/100
  • 100 - 250
  • - -
  • $25M - 100M
View ProfileView
Par Pharmaceutical's top 16 competitors are TEVA, Sandoz, Mylan, Allergan, Apotex, Bluefish Pharmaceuticals, Cipla, Dr.Reddy's, Beximco Pharma, Sagent, Genentech, Sun Pharma, Celgene, ANI, Strauss and Popular Pharmaceuticals. Together they have raised over 24.5B between their estimated 285.6K employees. Par Pharmaceutical's revenue is the ranked 12th among it's top 10 competitors. The top 10 competitors average 6.9B. Par Pharmaceutical has 1,600 employees and is ranked 14th among it's top 10 competitors. The top 10 competitors average 16,894.

Par Pharmaceutical VS TEVA

TEVA is perceived as one of Par Pharmaceutical's biggest rivals. TEVA was founded in 1901, and its headquarters is in Tel Aviv, Tel Aviv District. Like Par Pharmaceutical, TEVA also works within the Pharmaceuticals field. TEVA has 35,230 more employees than Par Pharmaceutical.

Par Pharmaceutical VS Sandoz

Sandoz is one of Par Pharmaceutical's top rivals. Sandoz is a Public company that was founded in 1886 in Holzkirchen, Basel-Country. Like Par Pharmaceutical, Sandoz also competes in the Pharmaceuticals sector. Compared to Par Pharmaceutical, Sandoz has 20,138 more employees.

Par Pharmaceutical VS Mylan

Mylan is Par Pharmaceutical's #3 rival. Mylan is a Private company that was founded in Canonsburg, Pennsylvania in 1961. Like Par Pharmaceutical, Mylan also operates in the Pharmaceuticals sector. Mylan has 36,400 more employees vs. Par Pharmaceutical.

Looking for similar companies to Par Pharmaceutical?

Similar Companies

Pharmaceuticals companies with revenue in $500M-1.0B range

See 95 companies 
Pharmaceuticals companies with employees in 1.0-5.0K range

See 203 companies 
Pharmaceuticals & Biotechnology companies with revenue in $500M-1.0B range

See 159 companies 
Companies in New York with revenue in $500M-1.0B range

See 310 companies 
Companies in New York Metropolitan Area with revenue in $500M-1.0B range

See 379 companies 
Pharmaceuticals & Biotechnology companies with employees in 1.0-5.0K range

See 399 companies 
Pharmaceuticals companies in New York

See 562 companies 
Companies in New York with employees in 1.0-5.0K range

See 816 companies 
Companies in New York Metropolitan Area with employees in 1.0-5.0K range

See 980 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Par Pharmaceutical and Par Pharmaceutical's Competitors

March 27, 2025Indian Pharma Post
Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206 and BAT2506...
March 25, 2025PR-Inside
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / March 25, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Corcept...
March 26, 2025The Economic Times
Kedaara Capital and TA Associates are in talks to acquire a significant minority stake in Sagent Pharma, valued at $500-600 million. Investment amounts...
March 25, 2025Marketscreener
Strauss Group Ltd. reported earnings results for the fourth quarter ended December 31, 2024. For the fourth quarter, the company reported sales was ILS...
March 25, 2025Drug Store News
Generic Alinia is used to treat diarrhea caused by certain parasites....
March 25, 2025Secunderabadchronicle
" Urticaria Pipeline Insight, 2025 " report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth p...
March 25, 2025Seeking Alpha
March 25, 2025Drug Store News
This sale includes its manufacturing facility in Shreveport, La....

Frequently Asked Questions about Par Pharmaceutical

  1. Who are Par Pharmaceutical's top competitors?

    Par Pharmaceutical's top 3 competitors are TEVA, Sandoz, Mylan.

  2. Who is similar to Par Pharmaceutical?

    TEVA is the most similar to Par Pharmaceutical. Sandoz and Mylan are also similar to Par Pharmaceutical.

  1. Are Par Pharmaceutical and TEVA competitors?

    Yes, TEVA is one of Par Pharmaceutical’s top competitors.